Insider Transactions
| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Aug 20, 2021 |
Director
Trans History: 4
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 65,886 | -- | 65,886 |
| Aug 20, 2021 |
Director
Trans History: 115
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 65,886 | -- | 218,113 |
| Aug 20, 2021 |
Director
Trans History: 126
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 65,886 | -- | 218,133 |
| Aug 22, 2022 |
Chief Financial Officer
Trans History: 19
|
Chief Financial Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 66,995 | $3.08 | 815,401 |
| Mar 12, 2014 |
Director
Trans History: 9
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 67,204 | -- | 67,204 |
| Mar 12, 2014 |
Director
Trans History: 121
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 67,204 | -- | 67,204 |
| Mar 12, 2014 |
Director
Trans History: 11
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 67,204 | -- | 67,204 |
| Mar 12, 2014 |
Director
Trans History: 23
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 67,204 | -- | 67,204 |
| Mar 12, 2014 |
Director
Trans History: 126
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 67,204 | -- | 67,204 |
| Mar 12, 2014 |
Director
Trans History: 12
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 67,204 | -- | 67,204 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.